The onset of hepatitis B, a disease that affects the liver and can lead to some types of cancer or cirrhosis, can be prevented with the vaccine.
According to the most recent bulletin published by the World Health Organization on the state of this disease throughout the world, as a result of increasing coverage of hepatitis B vaccines, “in an increasing number of countries, new generations are growing up increasingly free of HBV infection.”
The vaccine is recommended to be administered at birth. At six months, two follow-up shots are administered.
A hepatitis B infection can be acute or chronic. Acute hepatitis B is a short-term disease that occurs over a six-month period after the person is exposed to the virus. It can cause fever, fatigue, a lack of appetite, nausea, vomiting, jaundice (yellow eyes or skin, dark urine, clay-colored stools), muscle and joint pain and stomachaches.
Chronic hepatitis B is a long-term condition that occurs when a virus remains in the body. Most patients that develop it do not have symptoms; however, it can still cause liver damage (cirrhosis) as well as liver cancer.
Related article: Pregnancy, prevention and hepatitis B